Bolmstedt A, Sjölander S, Hansen J E, Akerblom L, Hemming A, Hu S L, Morein B, Olofsson S
Department of Clinical Virology, University of Göteborg, Sweden.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):213-20. doi: 10.1097/00042560-199607000-00001.
One of the functions of N-linked glycans of viral glycoproteins is protecting otherwise accessible neutralization epitopes of the viral envelope from neutralizing antibodies. The aim of the present study was to explore the possibility to obtain a more broadly neutralizing immune response by immunizing guinea pigs with gp160 depleted of three N-linked glycans in the CD4-binding domain by site-directed mutagenesis. Mutant and wild type gp160 were formulated into immunostimulating complexes and injected s.c. into guinea pigs. Both preparations induced high serum antibody response to native gp120 and V3 peptides. Both preparations also induced antibodies that bound equally well to the V3 loop or the CD4-binding region, as determined by a competitive enzyme-linked immunosorbent assay (ELISA). The sera from animals, immunized with mutated glycoprotein, did not neutralize nonrelated HIV strains better than did sera from animals, immunized with wild type glycoprotein. Instead, a pattern of preferred homologous neutralization was observed, i.e., sera from animals, immunized with mutant gp160, neutralized mutant virus better than wild type virus, and vice versa. These data indicated that elimination of the three N-linked glycans from gp160 resulted in an altered local antigenic conformation but did not uncover hidden neutralization epitopes, broadening the immune response.
病毒糖蛋白的N - 连接聚糖的功能之一是保护病毒包膜中原本可及的中和表位不被中和抗体识别。本研究的目的是探索通过用定点诱变去除CD4结合域中三个N - 连接聚糖的gp160免疫豚鼠,获得更广泛中和免疫反应的可能性。将突变型和野生型gp160制备成免疫刺激复合物,并皮下注射到豚鼠体内。两种制剂均诱导了对天然gp120和V3肽的高血清抗体反应。通过竞争性酶联免疫吸附测定(ELISA)确定,两种制剂还诱导了与V3环或CD4结合区域结合能力相同的抗体。用突变糖蛋白免疫的动物血清对无关HIV毒株的中和能力并不比用野生型糖蛋白免疫的动物血清更强。相反,观察到一种优先的同源中和模式,即用突变型gp160免疫的动物血清对突变病毒的中和能力比对野生型病毒更强,反之亦然。这些数据表明,从gp160中去除三个N - 连接聚糖会导致局部抗原构象改变,但不会暴露隐藏的中和表位,从而扩大免疫反应。